History
  • No items yet
midpage
In re Skelaxin (metaxalone) Antitrust Litigation
299 F.R.D. 555
E.D. Tenn.
2014
Read the full case

Background

  • Two putative classes were at issue: End Payors (indirect purchasers seeking damages and injunction) and Indirect Purchasers (nationwide and state-subclass indirect purchasers).
  • End Payors defined multiple damages subclasses plus an injunction class, all alleging overcharge from Skelaxin/metaxalone due to Defendants’ alleged anticompetitive conduct delaying generics.
  • Indirect Purchasers asserted nationwide and four state subclasses, seeking antitrust and unjust enrichment claims under multiple states’ laws.
  • The court held oral argument and ultimately denied class certification for both End Payors and Indirect Purchasers, citing ascertainability and choice-of-law/predominance issues.
  • A related motion to strike expert testimony and for partial summary judgment by End Payors was denied without prejudice due to lack of certification.

Issues

Issue Plaintiff's Argument Defendant's Argument Held
Ascertainability of End Payors damages class End Payors contends class is defined by objective criteria and administratively feasible. Defendants contend class requires transaction-by-transaction determinations and price-risk allocations, making ascertainability impossible. Denied; End Payors not ascertainable due to transaction-level determinations.
Comcast compatibility of damages model with liability theory Rausser model provides class-wide damages aligned with the alleged theory of injury. Model impermissibly includes non-end-payors and does not tie damages to the proposed theory, violating Comcast. Denied; damages model not consistent with liability theory under Comcast.
Nationwide Indirect Purchasers class—choice of law and predominance TTPA claims can be pursued nationwide; Freeman supports broad reach of TTPA. Choice-of-law and predominance require applying laws of multiple states; class would be unmanageable. Denied; nationwide class not certified; choice-of-law analysis favors non-Tennessee law and state-specific subclasses present manageability issues.
State-subclass viability and conflict-of-law analysis State-subclasses can avoid cross-state conflicts by applying each state's law where injury occurred. Even state-subclasses face predominance/ascertainability challenges and must be evaluated under Restatement §145 conflicts. Denied; state subclasses not certified due to anticipated conflicts and lack of manageable framework.

Key Cases Cited

  • Pilgrim v. Universal Health Card, LLC, 660 F.3d 943 (6th Cir.2011) (choice-of-law analysis required for nationwide class; multi-state differences hinder certification)
  • Relafen Antitrust Litig., 221 F.R.D. 260 (D. Mass. 2004) (multiple states; variations in state law affect predominance; some states omitted)
  • Comcast Corp. v. Behrend, 133 S. Ct. 1426 (2013) (damages model must be consistent with liability theory for Rule 23(b)(3) predominance)
  • In re Whirlpool Corp. Front-Loading Washer Prods. Liab. Litig., 722 F.3d 838 (6th Cir.2013) (some merits inquiry may be necessary; rigorous analysis required but not a trial on merits)
  • In re St. Jude Medical, Inc., 425 F.3d 1116 (8th Cir.2005) (choice-of-law analysis required; due process constraints on transferring law across states)
  • AT&T Mobility LLC v. Aio Optronics Corp., 707 F.3d 1106 (9th Cir.2013) (extraterritorial application of state laws; due process and significant contacts in choice-of-law)
  • Smyrna v. Mun. Gas Auth. of Ga., 723 F.3d 640 (6th Cir.2013) (Restatement §145 principles; considerations for conflicts and choice-of-law)
  • In re Flonase Antitrust Litig., 815 F. Supp. 2d 867 (E.D. Pa.2011) (state consumer protection/antitrust law variations affect class certification)
Read the full case

Case Details

Case Name: In re Skelaxin (metaxalone) Antitrust Litigation
Court Name: District Court, E.D. Tennessee
Date Published: Jan 30, 2014
Citation: 299 F.R.D. 555
Docket Number: No. 1:12-md-2343
Court Abbreviation: E.D. Tenn.